Nonnegligible Pestis
The history of human disease is closely related to the times. During the period of “hunger”, “starvation” was everywhere; in the dark ages, cholera, dysentery, and pestis had tortured and devoured many people. Nowadays, humans have entered the modern civilization era for a long time, and the living environment has been significantly improved. Due to […]
Dr. Li Yuanchao of Shanghai Institute of Materia Medica, Chinese Academy of Sciences Visited Guilin SanLengBio and Promoted Triptolide Cooperation Project
On January 23, 2018, Dr. Li Yuanchao of Shanghai Institute of Materia Medica, Chinese Academy of Sciences and his party visited Guilin SanLengBio to discuss and promote the triptolide cooperation project.
Dr. Li has been working in Shanghai Institute of Materia Medica since 1991 and has served as the team leader, researcher, and doctoral supervisor of the research group.
Colleen’s Dream helps TGen cancer research
Colleen’s Dream Foundation, a Scottsdale-based nonprofit, today announced a $30,000 grant to the Translational Genomics Research Institute (TGen) to research new ways of treating ovarian cancer.
The grant will help fund research that builds on TGen’s discovery that mutations in a gene known as SMARCA4 drive a specific type of extremely aggressive ovarian cancer — Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT) — which most often affects girls and young women.
Triptolide molecule can turn into cruise missile against cancer
More than 20 years ago, a billboard in China piqued the interest of a chemical biologist. It endorsed an extract from the plant known as the “thunder god vine” as an immunosuppressant. A brief review of published research revealed that the extract’s key ingredient — the small molecule triptolide — had been identified 20 years before that billboard ad, and it could stop cells from multiplying.
